These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 217196)

  • 1. [Selective chemotherapy of hepatocellular carcinomas].
    Keppler D; Pausch J; Gerok W
    Verh Dtsch Ges Inn Med; 1978; (84):606-10. PubMed ID: 217196
    [No Abstract]   [Full Text] [Related]  

  • 2. [Advanced hepatocellular carcinoma: value of systemic chemotherapy combining adriamycin, amiodarone and 5-fluorouracil].
    Bedenne L; Chauffert B; Lorcerie B; Faivre J; Hillon P; Klepping C; Martin F
    Gastroenterol Clin Biol; 1989 Oct; 13(10):845-6. PubMed ID: 2556316
    [No Abstract]   [Full Text] [Related]  

  • 3. Adriamycin and 5-fluorouracil in the treatment of advanced hepatoma: a Southwest Oncology Group study.
    Baker LH; Saiki JH; Jones SE; Hewlett JS; Brownlee RW; Stephens RL; Vaitkevicius VK
    Cancer Treat Rep; 1977 Nov; 61(8):1595-7. PubMed ID: 200359
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of primary liver cancer: response to regional chemotherapy.
    Wellwood JM; Cady B; Oberfield RA
    Clin Oncol; 1979 Mar; 5(1):25-31. PubMed ID: 217565
    [No Abstract]   [Full Text] [Related]  

  • 5. Evaluation of a chemotherapeutic regimen for primary liver cancer in children.
    Senzer NN; Terrell W; Pratt CB
    Cancer Treat Rep; 1978 Sep; 62(9):1403-4. PubMed ID: 210945
    [No Abstract]   [Full Text] [Related]  

  • 6. Receptor-mediated protection of normal hepatocytes during chemotherapy for hepatocellular carcinoma.
    Keegan-Rogers V; Wu CH; Wu GY
    Targeted Diagn Ther; 1991; 4():105-25. PubMed ID: 1665717
    [No Abstract]   [Full Text] [Related]  

  • 7. Medical treatment of hepatocellular carcinoma.
    Nerenstone S; Friedman M
    Gastroenterol Clin North Am; 1987 Dec; 16(4):603-12. PubMed ID: 2831153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Some data from a biochemical study of patients with primary cancer of the liver during chemotherapy].
    Pashintseva LP; Krusanova NI; Assekritova IV
    Vestn Akad Med Nauk SSSR; 1970; 25(2):39-43. PubMed ID: 4317645
    [No Abstract]   [Full Text] [Related]  

  • 9. [Approaches to a selective chemotherapy of hepatocellular carcinoma (author's transl)].
    Pausch J; Holstege A; Keppler D; Gerok W
    Klin Wochenschr; 1981 Jun; 59(12):591-8. PubMed ID: 6265689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neoadjuvant chemotherapy after liver transplantation for hepatocellular carcinoma.
    Rizzi PM; Ryder SD; Ramage JK; Gane E; Karani J; Heaton N; Portmann B; Tan KC; Williams R
    Transplant Proc; 1994 Dec; 26(6):3568-9. PubMed ID: 7527979
    [No Abstract]   [Full Text] [Related]  

  • 11. Incorporation of precursors and inhibitors of nucleic acid synthesis into hepatomas and liver of the rat.
    Lea MA; Khalil FL; Morris HP; Bullock J
    Cancer Res; 1974 Dec; 34(12):3414-20. PubMed ID: 4371961
    [No Abstract]   [Full Text] [Related]  

  • 12. Systemic cytostatic drug therapy in liver cancer.
    Glimelius B
    Ann Chir Gynaecol Suppl; 1986; 200():69-73. PubMed ID: 3014989
    [No Abstract]   [Full Text] [Related]  

  • 13. [Apropos of a hepatoma: rôle of regional chemotherapy].
    Bessot M; Thevenin F; Fays J; Grilliat JP
    Sem Hop; 1968 Jun; 44(29):1995-6. PubMed ID: 4299982
    [No Abstract]   [Full Text] [Related]  

  • 14. Prolonged survival with hepatocellular carcinoma.
    Penalba C; Larouze B; Mechali D; Saimot G; Coulaud JP
    Gastroenterology; 1982 Nov; 83(5):1159. PubMed ID: 6288508
    [No Abstract]   [Full Text] [Related]  

  • 15. Commentary 2008: 25 or 50 years later?
    Saletti P; Sessa C; Cavalli F
    J Clin Oncol; 2008 Oct; 26(30):4854-5. PubMed ID: 18794536
    [No Abstract]   [Full Text] [Related]  

  • 16. Polyamine depletion of tumor tissue and subsequent elevation of spermidine in the sera of rats with 3924A hepatomas after 5-fluorouracil administration.
    Russell DH; Looney WB; Kovacs CJ; Hopkins HA; Marton LJ; LeGendre SM; Morris HP
    Cancer Res; 1974 Sep; 34(9):2382-5. PubMed ID: 4367291
    [No Abstract]   [Full Text] [Related]  

  • 17. Continuous prolonged intrahepatic infusion of 5-fluorouracil in the treatment of hepatoma in Ibadan.
    Francis TI
    West Afr Med J Niger Pract; 1972 Feb; 21(1):18-20. PubMed ID: 4338412
    [No Abstract]   [Full Text] [Related]  

  • 18. Hepatocellular carcinoma responding to chemotherapy with 5-FU.
    Yoshida H; Onda M; Tajiri T; Umehara M; Mamada Y; Taniai N; Kaneko M; Mizuguchi Y; Uchida E; Yamashita K; Uchida E
    Hepatogastroenterology; 2000; 47(34):1120-1. PubMed ID: 11020893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Doxorubicin coupled to lactosaminated human albumin: a hepatocellular carcinoma targeted drug.
    Fiume L; Baglioni M; Bolondi L; Farina C; Di Stefano G
    Drug Discov Today; 2008 Nov; 13(21-22):1002-9. PubMed ID: 18755287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trial of adriamycin in primary hepatocellular carcinoma.
    Tsega E
    Ethiop Med J; 1984 Jan; 22(1):55-9. PubMed ID: 6317377
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.